Suit Co.,Ltd. amount Baht 6.74 million. The other income went up 38.08% amount to Baht 8.60 million. 2. The cost of medical treatments when compared to income from medical treatments increased 2.91% due
to Baht 0.009 million. 2. The cost of medical treatments when compared to income from medical treatments increased 6.41% due to the cost of medical treatments from CMR went up amount 11.76% from
4.14 million. 2. The cost of medical treatments when compared to income from medical treatments decreased 5.06% due to the cost of medical treatments from CMR went down 9.00% and the cost of medical
from the same period of last year due to loss on forward contract caused by foreign exchange volatility during the Covid-19 pandemic. 1.2 Cost of goods sold and expenses Consolidated financial statements
. The cost of medical treatments when compared to income from medical treatments decreased 5.06% due to the cost of medical treatments from CMR went down 9.00% and the cost of medical treatments in the
Portugal) and higher cost of raw materials. Profit after tax and NCI of $819 million, up 33% YoY. TRIS Rating (an S&P partner) upgrade IVL to AA- from its earlier rating of A+. Indorama Ventures 2018 MD
and the TFRS 9 revenue recognition concept adopted for calculation of interest income and fee income related to loan, as well as reduction of contributions to the Financial Institutions Development Fund
and Exchange Commission SorThor. 20/2554 Calculation and Report of Net Liquid Capital Calculation (No. 5) 23/06/2011 01/07/2011 13. Notification of the Office of the Securities and Exchange
. 20/2554 Calculation and Report of Net Liquid Capital Calculation (No. 5) 23/06/2011 01/07/2011 10. Notification of the Office of the Securities and Exchange Commission SorThor/Nor. 18/2554 Reporting
and Exchange Commission SorThor. 20/2554 Calculation and Report of Net Liquid Capital Calculation (No. 5) 23/06/2011 01/07/2011 13. Notification of the Office of the Securities and Exchange